IMBRUVICA
Generic: IBRUTINIB
Pharmacyclics LLCManufacturer
ORALRoute
IBRUTINIBActive Substance
2022-08-24Original Approval
IMBRUVICA is FDA application NDA217003, sponsored by PHARMACYCLICS LLC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DEATH
8,579 reports
2
OFF LABEL USE
6,002 reports
3
FATIGUE
4,752 reports
4
DIARRHOEA
4,191 reports
5
ATRIAL FIBRILLATION
3,894 reports
6
PNEUMONIA
3,263 reports
7
CONTUSION
2,820 reports
8
INCORRECT DOSE ADMINISTERED
2,778 reports
9
FALL
2,527 reports
10
ASTHENIA
2,358 reports